Bajaj Healthcare Limited

Web: bajajhealth.com NSE: BAJAJHCARE BSE: 539872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

319 4(-1%)

Volume

2L as on 23, Jun

Open

569

High

589

Low

550

323

VWAP

316

52 Week High

544

52 Week Low

272

Viand Research Rating

Quality Score

60/100

Growth Score

66/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,074

No. of Shares

3.37

P/E

-80.33

P/B

4.48

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-5.58

ROCE

Profit Growth

Listing Date

25-Nov-21

Promoter Holding

58.59%

FII Holding

2.19%

DII Holding

1.92%

Price Chart

Price Performance

1 Week4%

1 Month3%

3 Months3%

6 Months0%

1 Year0%

YTD0%

Moving Average

5 Day SMA312

10 Day SMA304

20 Day SMA301

30 Day SMA299

50 Day SMA312

61 Day SMA312

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	328	320	325	327
Resistance 2	325	319	322	325
Resistance 1	321	318	321	321
Pivot Point	318	318	318	318
Support 1	315	317	316	315
Support 2	312	317	315	312
Support 3	309	316	312	308

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.31) 58.59%	(-0.91) 58.29%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(-8.61) 59.19%	(0.01) 67.74%	(0.01) 67.74%	(0.01) 67.73%	(0.21) 67.69%	(0.01) 67.49%	(0.11) 67.49%	(0.11) 67.42%	(0.01) 67.30%	(0.01) 67.30%	(0.01) 67.26%	(0.01) 67.26%	(0.01) 67.26%
FIIs	(0.21) 2.19%	(0.81) 1.98%	(0.11) 1.18%	(0.01) 1.12%	(0.01) 1.09%	(0.01) 1.05%	(-0.11) 1.01%	(1.11) 1.07%	(-0.51) 0.00%	(-0.21) 0.53%	(0.11) 0.74%	(0.01) 0.66%	(-0.11) 0.69%	(-0.21) 0.78%	(0.91) 0.94%	(-0.21) 0.09%	(-0.11) 0.32%	(0.11) 0.38%	(0.01) 0.32%	(0.01) 0.34%
DIIs	(-1.01) 1.92%	(0.01) 2.91%	(0.01) 2.96%	(-0.21) 2.99%	(0.61) 3.16%	(0.21) 2.52%	(0.41) 2.36%	(2.01) 1.97%	(-0.41) 0.00%	(-0.11) 0.43%	(0.11) 0.48%	(0.11) 0.43%	(0.01) 0.34%	(0.01) 0.34%	(0.31) 0.34%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	37.30%	36.82%	36.67%	36.70%	36.56%	37.25%	37.45%	37.77%	32.27%	31.31%	31.06%	31.22%	31.48%	31.38%	31.30%	32.62%	32.38%	32.36%	32.42%	32.39%
No. of Shareholders	41,310	38,158	37,953	38,576	35,980	35,710	32,672	31,995	32,397	32,712	29,626	28,008	27,322	26,037	26,930	29,769	30,909	30,723	32,309	26,707

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Sales	166	153	161	148	149	154	123	133	132	134	109	101	130	154	133	195	172	176	167.57
Sales Growth % (YoY)	11.3%	-0.9%	31.3%	11.1%	12.5%	15.4%	13.1%	31.5%	1.9%	-13.1%	-18.1%	-48.2%	-24.6%	-	-	-	-	32.9%	-6%
Sales Growth % (QoQ)	8.5%	-5%	8.8%	-0.7%	-3.2%	25.2%	-7.5%	0.8%	-1.5%	22.9%	7.9%	-22.3%	-15.6%	15.8%	-31.8%	13.4%	-2.3%	5%	-
Expenses	137	130	131	121	124	143	101	109	108	118	89	82	108	132	102	161	146	150	136.75
Operating Profit	29	23	31	27	25	12	22	25	24	16	20	19	22	22	30	34	26	25	30.82
OPM %	17	15	19	18	16	8	18	18	19	12	18	19	17	14	23	18	15	14	18.39
Other Income	1	-34	1	0	1	13	-1	4	0	-36	-7	-7	-55	-7	-6	-5	1	0	0.2
Interest	6	6	6	6	5	6	6	8	8	6	7	8	9	6	5	4	4	4	2.84
Depreciation	7	8	7	7	6	8	7	7	7	7	7	7	6	5	4	4	7	4	4.86
Profit before tax	16	-24	19	15	14	11	8	14	9	-33	-1	-3	-48	5	15	22	16	17	23.32
Tax %	16	-6	17	24	17	1	-39	30	23	-10	58	4	0	21	26	26	26	-3	25.21
Net Profit	14	-23	16	11	12	11	12	9	7	-30	-2	-3	-48	4	11	16	12	17	17.45
Net Profit Growth % (QoQ)	160.9%	-243.8%	45.5%	-8.3%	9.1%	-8.3%	33.3%	28.6%	123.3%	-1400%	33.3%	93.8%	-1300%	-63.6%	-31.2%	33.3%	-29.4%	-2.6%	-
Net Profit Growth % (YoY)	16.7%	-309.1%	33.3%	22.2%	71.4%	136.7%	700%	400%	114.6%	-850%	-118.2%	-118.8%	-500%	-76.5%	-37%	-	-	-	-
TTM Net Profit	18	16	50	46	44	39	-2	-16	-28	-83	-49	-36	-17	43	56	62.45	46.45	34.45	0
EPS in Rs	4.07	-6.79	4.96	3.52	3.75	3.54	3.71	3	2.58	-10.84	-0.8	-1.25	-17.47	1.3	4	5.93	4.36	6.33	6.32

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	611	543	473	646	680	657	410	370	327	231	223	218	205	171
Sales Growth %	12.6%	14.6%	-26.7%	-5%	3.5%	60.2%	10.8%	13.2%	41.8%	3.5%	2.1%	6.5%	20%	20.7%
Expenses	506	460	397	534	561	521	362	327	288	200	193	189	186	158
Operating Profit	105	83	76	112	119	136	48	43	39	31	30	29	19	13
OPM %	17	15	16	17	17	21	12	12	12	13	14	13	9	7
Other Income	-32	16	-105	-19	1	7	7	1	2	2	0	0	0	0
Interest	22	28	30	18	13	8	7	8	8	8	8	8	7	6
Depreciation	28	28	28	17	18	16	12	11	11	11	9	9	9	8
Profit before tax	23	43	-86	58	90	119	36	24	23	14	14	12	3	-2
Tax %	33	7	-3	25	20	30	30	33	33	43	39	37	40	-31
Net Profit	16	40	-84	43	71	83	25	16	15	8	8	8	2	-1
Net Profit Growth %	-60%	147.6%	-295.3%	-39.4%	-14.5%	232%	56.2%	6.7%	87.5%	-	-	300%	300%	-
EPS in Rs	4.68	12.51	-30.36	15.59	25.87	30.11	9.14	5.91	5.5	2.83	3.04	8.34	2.19	-1.18
Dividend Payout %	32	8	-3	6	6	5	0	0	5	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	58	22	92	-22	1	44	21	25	17	22	25	28	17	14
Cash from Investing Activity	-48	-15	-11	-93	-75	-109	-28	-13	-12	-8	-31	-17	-9	-8
Cash from Financing Activity	24	-6	-97	131	62	75	3	-13	2	-13	5	-11	-8	-7
Net Cash Flow	35	0	-16	16	-12	10	-4	0	7	0	0	0	1	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	17	16	16	16	14	14	14	14	14	7	7	7	7	2	2	2
Reserves	516	471	450	430	265	354	315	245	164	122	107	92	82	78	28	26
Borrowings	249	238	223	206	333	415	257	181	91	81	87	75	81	70	72	72
Other Liabilities	141	114	144	152	154	115	136	86	74	57	68	45	39	38	43	31
Total Liabilities	923	839	833	804	765	898	721	526	343	267	268	219	209	189	145	131
Fixed Assets	248	251	238	240	253	366	270	208	162	128	127	128	130	108	56	54
CWIP	8	6	3	10	7	22	52	57	5	1	2	0	1	1	3	5
Investments	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0
Other Assets	667	582	591	554	506	510	399	260	170	137	140	91	78	79	87	72
Total Assets	923	839	833	804	765	898	721	526	343	267	268	219	209	189	145	131

Delivery

#	Date	272 45% 394	Value (Cr)	Q/T 55	Del 29	Del 13
1	22-Jul	323	55	44	36	20
2	21-Jul	369	34	43	31	11
3	20-Jul	387	39	46	40	16
4	17-Jul	374	11	40	37	4
5	16-Jul	373	26	36	40	10
6	15-Jul	364	15	41	53	8
7	14-Jul	348	7	30	43	3
8	13-Jul	343	6	44	47	3
9	10-Jul	349	5	39	51	2
10	9-Jul	350	19	32	40	8
11	8-Jul	335	7	29	39	3
12	7-Jul	332	4	32	51	2
13	6-Jul	336	4	29	44	2
14	3-Jul	345	5	32	33	2
15	2-Jul	342	12	48	27	3
16	1-Jul	345	12	46	27	3
17	30-Jun	351	68	70	19	13
18	29-Jun	353	525	87	5	25
19	25-Jun	304	4	48	37	2
20	24-Jun	311	5	56	40	2
21	23-Jun	313	5	53	38	2
22	22-Jun	318	4	44	47	2
23	19-Jun	313	6	43	49	3
24	18-Jun	317	32	48	26	8
25	17-Jun	299	3	47	53	2
26	16-Jun	302	4	40	51	2
27	15-Jun	299	7	49	48	3
28	12-Jun	304	10	50	43	5
29	11-Jun	283	4	53	49	2
30	10-Jun	291	2	44	52	1
31	9-Jun	292	3	59	50	2
32	8-Jun	291	4	59	27	1
33	5-Jun	294	2	37	46	1
34	4-Jun	295	5	61	41	2
35	3-Jun	299	2	26	50	1
36	2-Jun	300	2	34	41	1
37	1-Jun	294	9	40	33	3
38	29-May	302	4	31	53	2
39	27-May	307	7	43	19	1
40	26-May	305	3	46	27	1
41	25-May	302	3	34	51	1
42	22-May	306	2	28	36	1
43	21-May	304	6	39	43	3
44	20-May	299	4	32	40	2
45	19-May	289	11	22	42	5
46	18-May	275	4	35	53	2
47	15-May	284	7	39	42	3
48	14-May	294	2	30	34	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	1,074c	7c	0.64
22-Jul	1,081c	158c	12.77
21-Jul	1,239c	17c	1.38
17-Jul	1,256c	2c	0.17
16-Jul	1,258c	86c	7.37
15-Jul	1,172c	29c	2.52
14-Jul	1,143c	25c	2.13
13-Jul	1,168c	15c	1.22
10-Jul	1,183c	2c	0.17
09-Jul	1,185c	52c	4.58
08-Jul	1,133c	15c	1.34
07-Jul	1,118c	19c	1.67
06-Jul	1,137c	25c	2.12
02-Jul	1,161c	17c	1.43
30-Jun	1,178c	2c	0.16
29-Jun	1,180c	151c	14.63
26-Jun	1,029c	6c	0.59
25-Jun	1,036c	10c	0.98
24-Jun	1,046c	14c	1.27
23-Jun	1,059c	6c	0.55
22-Jun	1,065c	3c	0.24
19-Jun	1,063c	53c	5.25
17-Jun	1,010c	5c	0.45
16-Jun	1,014c	4c	0.43
15-Jun	1,010c	9c	0.89
12-Jun	1,019c	36c	3.70
11-Jun	982c	9c	0.95
10-Jun	992c	0	0

Stock Checklist

Price is below from 52 week high low average: 66%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Jul26 · Total value ₹40 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	2	0.77%	-0.08%	40
Bandhan Mutual Fund	2	0.03%	-	0

Bajaj Healthcare Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements